Professional Documents
Culture Documents
Prohibited List: International Standard
Prohibited List: International Standard
Prohibited List: International Standard
INTERNATIONAL
STANDARD
The official text of the Prohibited List shall be maintained by WADA and shall be published in English and French.
In the event of any conflict between the English and French versions, the English version shall prevail.
IN ACCORDANCE WITH ARTICLE 4.2.2 OF THE WORLD ANTI-DOPING CODE, ALL PROHIBITED SUBSTANCES SHALL
BE CONSIDERED AS SPECIFIED SUBSTANCES EXCEPT SUBSTANCES IN CLASSES S1, S2, S4.4, S4.5, S6.A, AND
PROHIBITED METHODS M1, M2 AND M3.
PROHIBITED SUBSTANCES
Mestanolone;
NON-APPROVED SUBSTANCES
S0 Any pharmacological substance which is not
Mesterolone;
Metandienone (17-hydroxy-17-methylandrosta-1,4-dien-
addressed by any of the subsequent sections of the
3-one);
Listand with no current approval by any governmental
Metenolone;
regulatory health authority for human therapeutic use
Methandriol;
(e.g.drugs under pre-clinical or clinical development
Methasterone (17-hydroxy-2,17-dimethyl-5-
ordiscontinued, designer drugs, substances approved
androstan-3-one);
onlyfor veterinary use) is prohibited at all times.
Methyldienolone (17-hydroxy-17-methylestra-4,9-dien-
3-one);
Methyl-1-testosterone (17-hydroxy-17-methyl-5-
ANABOLIC AGENTS
S1 Anabolic agents are prohibited.
androst-1-en-3-one);
Methylnortestosterone (17-hydroxy-17-methylestr-4-en-
3-one);
1. ANABOLIC ANDROGENIC STEROIDS (AAS) Methyltestosterone;
a. Exogenous* AAS, including: Metribolone (methyltrienolone, 17-hydroxy-17-
methylestra-4,9,11-trien-3-one);
1-Androstenediol (5-androst-1-ene-3,17-diol); Mibolerone;
1-Androstenedione (5-androst-1-ene-3,17-dione); Norboletone;
1-Testosterone (17-hydroxy-5-androst-1-en-3-one); Norclostebol;
4-Hydroxytestosterone (4,17-dihydroxyandrost-4-en-3-one); Norethandrolone;
Bolandiol (estr-4-ene-3,17-diol); Oxabolone;
Bolasterone; Oxandrolone;
Calusterone; Oxymesterone;
Clostebol; Oxymetholone;
Danazol ([1,2]oxazolo[4',5':2,3]pregna-4-en-20-yn-17-ol); Prostanozol (17-[(tetrahydropyran-2-yl)oxy]-1'H-
Dehydrochlormethyltestosterone (4-chloro-17-hydroxy- pyrazolo[3,4:2,3]-5-androstane);
17-methylandrosta-1,4-dien-3-one); Quinbolone;
Desoxymethyltestosterone (17-methyl-5-androst- Stanozolol;
2-en-17-ol); Stenbolone;
Drostanolone; Tetrahydrogestrinone (17-hydroxy-18a-homo-19-nor-17-
Ethylestrenol (19-norpregna-4-en-17-ol); pregna-4,9,11-trien-3-one);
Fluoxymesterone; Trenbolone (17-hydroxyestr-4,9,11-trien-3-one);
Formebolone;
Furazabol (17-methyl [1,2,5]oxadiazolo[3',4':2,3]-5- and other substances with a similar chemical structure
androstan-17-ol); orsimilar biological effect(s).
Gestrinone;
2
b. Endogenous** AAS when administered exogenously: 2. OTHER ANABOLIC AGENTS
3
3. Chorionic Gonadotrophin (CG) and Luteinizing Hormone Except:
(LH) and their releasing factors, e.g. buserelin, Inhaled salbutamol: maximum 1600 micrograms over
gonadorelin and leuprorelin, in males. 24hours, not to exceed 800 micrograms every 12 hours;
Inhaled formoterol: maximum delivered dose of
4. Corticotrophins and their releasing factors, 54micrograms over 24 hours;
e.g. corticorelin. Inhaled salmeterol: maximum 200 micrograms over
24hours.
5. Growth Hormone (GH) and its releasing factors including:
Growth Hormone Releasing Hormone (GHRH) and its The presence in urine of salbutamol in excess of 1000 ng/mL
analogues, e.g. CJC-1295, sermorelin and or formoterol in excess of 40 ng/mL is presumed not to be
tesamorelin; an intended therapeutic use of the substance and will be
Growth Hormone Secretagogues (GHS), e.g. ghrelin considered as an Adverse Analytical Finding ( AAF ) unless
and ghrelin mimetics, e.g. anamorelin and ipamorelin; the Athlete proves, through a controlled pharmacokinetic
GH-Releasing Peptides (GHRPs), e.g. alexamorelin, study, that the abnormal result was the consequence of
GHRP-6, hexarelin, and pralmorelin (GHRP-2). the use of the therapeutic dose (by inhalation) up to the
maximum dose indicated above.
Additional prohibited growth factors:
4
4. Agents modifying myostatin function(s) including, but
PROHIBITED METHODS
not limited, to: myostatin inhibitors.
5
SUBSTANCES & METHODS
PROHIBITED IN-COMPETITION
PROHIBITED SUBSTANCES
STIMULANTS
S6 All stimulants, including all optical isomers, e.g. b: Specified Stimulants.
d- and l- where relevant, are prohibited. Including, but not limited to:
6
Selegiline; NARCOTICS
Sibutramine;
S7
Strychnine; Prohibited:
Tenamfetamine (methylenedioxyamphetamine); Buprenorphine;
Tuaminoheptane; Dextromoramide;
Diamorphine (heroin);
and other substances with a similar chemical structure Fentanyl and its derivatives;
orsimilar biological effect(s). Hydromorphone;
Methadone;
Except: Morphine;
Clonidine; Nicomorphine;
Imidazole derivatives for topical/ophthalmic use and Oxycodone;
those stimulants included in the 2017 Monitoring Oxymorphone;
Program*. Pentazocine;
Pethidine.
* Bupropion, caffeine, nicotine, phenylephrine,
phenylpropanolamine, pipradrol, and synephrine: These
substances are included in the 2017 Monitoring Program, and
are not considered Prohibited Substances. CANNABINOIDS
** Cathine: Prohibited when its concentration in urine is greater S8
than 5 micrograms per milliliter.
*** Ephedrine and methylephedrine: Prohibited when the Prohibited:
concentration of either in urine is greater than 10 micrograms
Natural, e.g. cannabis, hashish and marijuana, or
per milliliter.
**** Epinephrine (adrenaline): Not prohibited in local administration, synthetic 9-tetrahydrocannabinol (THC).
e.g. nasal, ophthalmologic, or co-administration with local Cannabimimetics, e.g. Spice, JWH-018, JWH-073,
anaesthetic agents.
***** Pseudoephedrine: Prohibited when its concentration in urine HU-210.
isgreater than 150 micrograms per milliliter.
GLUCOCORTICOIDS
S9 All glucocorticoids are prohibited when administered
by oral, intravenous, intramuscular, or rectal routes.
7
SUBSTANCES PROHIBITED
IN PARTICULAR SPORTS
ALCOHOL BETA-BLOCKERS
P1 Alcohol (ethanol) is prohibited In-Competition only,
P2 Beta-blockers are prohibited In-Competition only, in
in the following sports. Detection will be conducted by the following sports, and also prohibited Out-of-Competition
analysis of breath and/or blood. The doping violation where indicated.
threshold is equivalent to a blood alcohol concentration
of0.10 g/L. Archery (WA)*
Air Sports (FAI) Automobile (FIA) Automobile (FIA)
Archery (WA) Powerboating (UIM) Billiards (all disciplines) (WCBS)
Darts (WDF)
Golf (IGF)
Shooting (ISSF, IPC)*
Skiing/Snowboarding (FIS) in ski jumping, freestyle
aerials/halfpipe and snowboard halfpipe/big air
Underwater sports (CMAS) in constant-weight apnoea
with or without fins, dynamic apnoea with and without
fins, free immersion apnoea, Jump Blue apnoea,
spearfishing, static apnoea, target shooting, and variable
weight apnoea.
Acebutolol; Labetalol;
Alprenolol; Levobunolol;
Atenolol; Metipranolol;
Betaxolol; Metoprolol;
Bisoprolol; Nadolol;
Bunolol; Oxprenolol;
Carteolol; Pindolol;
Carvedilol; Propranolol;
Celiprolol; Sotalol;
Esmolol; Timolol.
8
www.wada-ama.org